EMD and/or Bone Substitute for the Treatment of Class II Furcations
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
To clinically evaluate the treatment of mandibular class II furcation defects with enamel
matrix derivative (EMD) and/or a bone substitute graft make of beta tricalcium
phosphate/hydroxyapatite (βTCP/HA).